CAMH ranks among Canada's top three medium-sized research hospitals

On January 31, 2023, Research Infosource released its 2022 rankings (based on the 2020-21 fiscal year) for Canada’s Top 40 Research Hospitals.

CAMH has once again topped the list as the country’s leading mental health research hospital. During the 2020-21 fiscal year, Research Infosource reports that CAMH reached $79.7 million in research spending, a new record high and a 5.4 per cent increase over the prior year, reflecting the continued importance of mental health and addictions research to CAMH’s overall mandate. Looking forward, CAMH anticipates additional growth and productivity, with its research-related spending for 2021-22 recorded as $86.6 million.

In the 2022 rankings, CAMH maintained its position within its sub-category of medium-sized hospitals at 3rd overall in ‘researcher intensity,’ the amount of research spending per researcher. CAMH also maintained its 2nd place position for ‘hospital intensity,’ which analyzes research spending as a percentage of total hospital spending.

Overall CAMH came in 14th among the country’s top 40 leading research hospitals, funding a variety of research with a focus in areas such as cannabis, psychedelics, treatment-resistant depression, COVID-19’s impact on the brain and nervous system, dementia, posttraumatic stress disorder, postpartum depression, schizophrenia and psychosis, including the world largest ongoing clinical trial for the detection and prevention of first episode psychosis in young Canadians.

Some of last year’s stand-out research stories included:

• The launch of the The Toronto Adolescent & Youth Cohort study (TAY) via the Cundill, McCain, and Slaight Centres on the diagnosis and prevention of youth psychosis, the largest ongoing study of its kind on the world.
• A first-of-its-kind study in the New England Journal of Medicine on the use of psilocybin for treatment-resistant depression, and the launch of CAMH’s Clinical Trials Unit.
• Growing CAMH’s BrainHealth Databank  via the Krembil Centre for Neuroinformatics to drive data-driven discoveries and innovations that will improve patient care;
• Maintaining its position a world leader in the use of positron emission tomography (PET) imaging in brain research, at the CAMH Brain Health Imaging Centre and Azrieli Centre for Neuro-Radiochemistry for clinical treatment of mental illness and addiction, and the development of new drugs to treat mental illness.

Check out the complete list of Canada’s Top 40 Research Hospitals in 2022.

Read how CAMH did in last year’s rankings.

Find out more about research at CAMH.